BiotechTube
Home/Nacuity Pharmaceuticals/Charles Lieser, JD, CPA
CL

Charles Lieser, JD, CPA

CFO

Nacuity Pharmaceuticals

Therapeutic Areas

OphthalmologyRare Diseases

Nacuity Pharmaceuticals Pipeline

DrugIndicationPhase
NPI-001Retinitis PigmentosaPhase 2/3

Leadership Team at Nacuity Pharmaceuticals

HC
Halden Conner
Chairman, CEO, Co-Founder
GM
G. Michael Wall, PhD
SVP, Chief Scientific Officer
JR
Jami R. Kern, MBA, PhD
SVP, Chief Clinical Officer
LA
Lee Anderson, MD
Ophthalmologist in Residence
View full Nacuity Pharmaceuticals profile